Recombinant Microbial Lipase SLV339 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
298	Hereditary pancreatitis	1

298. Hereditary pancreatitis

Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00630279 (ClinicalTrials.gov)	February 2008	22/2/2008	Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chroni ...	A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to ...	Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis	Drug: Placebo;Drug: Recombinant Microbial Lipase SLV339	Solvay Pharmaceuticals	NULL	Terminated	18 Years	N/A	Both	56	Phase 2	Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden

First Previous1Next Last